Lin Xia

4.2k total citations · 1 hit paper
84 papers, 2.8k citations indexed

About

Lin Xia is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lin Xia has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 25 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lin Xia's work include MicroRNA in disease regulation (10 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Lin Xia is often cited by papers focused on MicroRNA in disease regulation (10 papers), Gastrointestinal Tumor Research and Treatment (6 papers) and Circular RNAs in diseases (6 papers). Lin Xia collaborates with scholars based in China, United States and Hong Kong. Lin Xia's co-authors include Rui Du, Daiming Fan, Shiren Sun, Yanglin Pan, Lina Zhao, Xiaoting Wu, Jie Liu, Dexin Zhang, Liu Hong and Yong Wang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Lin Xia

75 papers receiving 2.7k citations

Hit Papers

miR‐15b and miR‐16 modulate multidrug resistance by targe... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lin Xia China 28 1.5k 1.1k 615 398 320 84 2.8k
Kohei Taniguchi Japan 26 1.5k 1.0× 1.2k 1.1× 367 0.6× 282 0.7× 271 0.8× 153 2.5k
Ying Chang China 26 1.5k 1.0× 1.1k 1.1× 542 0.9× 445 1.1× 524 1.6× 64 2.9k
Xiaodong Yang China 25 1.1k 0.7× 676 0.6× 841 1.4× 390 1.0× 182 0.6× 77 2.3k
Shan Wang China 28 1.3k 0.9× 697 0.6× 1.1k 1.8× 488 1.2× 477 1.5× 126 3.0k
Seok Yun Kang South Korea 24 1.4k 0.9× 1.2k 1.1× 704 1.1× 598 1.5× 230 0.7× 111 2.7k
Tsuyoshi Noguchi Japan 31 1.8k 1.2× 666 0.6× 1.0k 1.7× 532 1.3× 834 2.6× 139 3.4k
Taishi Hata Japan 30 1.1k 0.8× 826 0.8× 1.2k 2.0× 495 1.2× 783 2.4× 222 3.0k
Bangshun He China 23 1.0k 0.7× 683 0.6× 952 1.5× 397 1.0× 451 1.4× 92 2.6k
Gregory Kouraklis Greece 32 1.2k 0.8× 463 0.4× 737 1.2× 444 1.1× 859 2.7× 142 3.1k

Countries citing papers authored by Lin Xia

Since Specialization
Citations

This map shows the geographic impact of Lin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xia more than expected).

Fields of papers citing papers by Lin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xia. The network helps show where Lin Xia may publish in the future.

Co-authorship network of co-authors of Lin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xia. A scholar is included among the top collaborators of Lin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xia. Lin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xia, Lin, Qunfang Yang, K.K. Fu, et al.. (2025). Unveiling the renoprotective mechanisms of self-assembled herbal nanoparticles from Scutellaria barbata and Scleromitrion diffusum in acute kidney injury: A nano-TCM approach. Acta Pharmaceutica Sinica B. 15(8). 4265–4284. 1 indexed citations
2.
Xia, Lin, et al.. (2024). Population pharmacokinetics of cyclosporine A in hematopoietic stem cell transplant recipients: A systematic review. European Journal of Pharmaceutical Sciences. 204. 106882–106882. 2 indexed citations
3.
4.
Xia, Lin, Maoxiao Feng, Yidan Ren, et al.. (2023). DSE inhibits melanoma progression by regulating tumor immune cell infiltration and VCAN. Cell Death Discovery. 9(1). 373–373. 2 indexed citations
5.
Wan, Qianyi, Rui Zhao, Yi Chen, et al.. (2023). Low Skeletal Muscle Mass and the Incidence of Delirium in Hospitalized Older Patients: A Systematic Review and Meta-Analysis of Observational Studies. International Journal of Clinical Practice. 2023. 1–9. 3 indexed citations
6.
Xia, Lin, Junyi Liu, Yujie Chen, et al.. (2021). Targeting Triple-Negative Breast Cancer with Combination Therapy of EGFR CAR T Cells and CDK7 Inhibition. Cancer Immunology Research. 9(6). 707–722. 55 indexed citations
7.
Wan, Qianyi, Rui Zhao, Lin Xia, et al.. (2021). Inflammatory bowel disease and risk of gastric, small bowel and colorectal cancer: a meta-analysis of 26 observational studies. Journal of Cancer Research and Clinical Oncology. 147(4). 1077–1087. 41 indexed citations
9.
Xia, Lin, Rui Zhao, Qianyi Wan, et al.. (2020). Sarcopenia and adverse health‐related outcomes: An umbrella review of meta‐analyses of observational studies. Cancer Medicine. 9(21). 7964–7978. 207 indexed citations
10.
Wang, Yong, et al.. (2019). Predictive Risk Factors of Intestinal Necrosis in Patients with Mesenteric Venous Thrombosis: Retrospective Study from a Single Center. Canadian Journal of Gastroenterology and Hepatology. 2019. 1–6. 17 indexed citations
11.
Xia, Lin, Daning Wang, Yuanzhi Chen, et al.. (2016). A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5. Scientific Reports. 6(1). 19042–19042. 14 indexed citations
12.
Xia, Lin, et al.. (2015). Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy. SHILAP Revista de lepidopterología. 5 indexed citations
13.
Xia, Lin, Juan Zhang, Junhui Xiong, et al.. (2015). In vitroaffinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay. The Journal of Biochemistry. 158(6). mvv070–mvv070. 1 indexed citations
14.
Zhu, Siying, et al.. (2014). Activation of the Interleukin-34 Inflammatory Pathway in Response to Influenza A Virus Infection. The American Journal of the Medical Sciences. 349(2). 145–150. 21 indexed citations
15.
Du, Rui, Lin Xia, Xiaoxuan Ning, et al.. (2014). Hypoxia-induced Bmi1 promotes renal tubular epithelial cell–mesenchymal transition and renal fibrosis via PI3K/Akt signal. Molecular Biology of the Cell. 25(17). 2650–2659. 100 indexed citations
16.
Zhou, Fei, Ning Li, Weihua Jiang, et al.. (2012). Prognosis significance of HER-2/neu overexpression/amplification in Chinese patients with curatively resected gastric cancer after the ToGA clinical trial. World Journal of Surgical Oncology. 10(1). 274–274. 35 indexed citations
17.
Liu, Yanjun, et al.. (2009). Synchronous incidental gastrointestinal stromal and epithelial malignant tumors. World Journal of Gastroenterology. 15(16). 2027–2027. 49 indexed citations
18.
Xia, Lin. (2007). A Survival Analysis of Nasopharyngeal Carcinoma from 1995 to 2004 in Sihui,Guangdong. 2 indexed citations
19.
Xia, Lin. (2002). MELT INCLUSIONS IN MAGMATIC ROCKS. Earth Science Frontiers. 2 indexed citations
20.
Zouboulis, Christos C., Bernhard Korge, Lin Xia, et al.. (1991). Wirkungen von Retinoiden auf Proliferation und Differenzierung humaner Talgdrüsenzellen in einem In-vitro-Modell. 66. 23–28. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026